Dr. P.J. Lugtenburg

Update Persondata

• cell
• costs
• disease
• patients
• receptor
• resistance
• treatment
• women

Active as

Publications

(the most recent at the top)

Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: A randomized, placebo-controlled trial

Economic evaluation of posaconazole versus fluconazole prophylaxis in patients with graft-versus-host disease (GVHD) in the Netherlands

Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: An observational study

Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: A randomized, placebo-controlled trial

Anti-müllerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies

All publications..

Current research

(the most recent research is at the top)
Project leader	Phase II study on the feasibility and efficacy of consolidation with 90y-ibritumomab tiuxetan in patients with relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma having achieved partial or complete remission after induction with R-RECC chemotherapy (HOVON 85 NHL)